Article Sidebar

PDF
Date Published: 17/10/2022
Abstract Views: 978
Views PDF: 124
DOI: https://doi.org/10.51298/vmj.v519i1.3509
Issue
Vol. 519 No. 1 (2022)
Section
Các bài báo
How to Cite
Văn Cường, T. ., Duy Linh, N. ., Nguyễn Đại Nghĩa, P. ., & Bùi Hải, H. . (2022). THE VALUE OF SPESI INDEX AND CRP-HS IN PREDICTING MORTALITY ON THE 30TH DAY OF PATIENTS WITH PULMONARY EMBOLISM (PE). Vietnam Medical Journal, 519(1). https://doi.org/10.51298/vmj.v519i1.3509

THE VALUE OF SPESI INDEX AND CRP-HS IN PREDICTING MORTALITY ON THE 30TH DAY OF PATIENTS WITH PULMONARY EMBOLISM (PE)

Trần Văn Cường1, Nguyễn Duy Linh2, Phan Nguyễn Đại Nghĩa1, Hoàng Bùi Hải1,
1 Hanoi Medical University
2 Vietnam National Heart Institute, Bach Mai Hospital

Main Article Content

Abstract

Objective: The purpose of this study was to indicate the value of sPESI index and CRP-hs in predicting mortality on the 30th day of patients with pulmonary embolism (PE).Methods: 162 patients were diagnosed with pulmonary embolism by multislice computed tomography (MSCT) pulmonary artery with contrast-enhanced with 27 mortality (16.67%) in 30 days. Results: The independence value of sPESI index and CRP-hs were moderate with AUC 0.74 and 0.65 respectively included the low specificity and mortality predictive value. When using 2 criteria simultaneously, sPESI and CRP-hs was not only higher specificity (93.9%) but also better positive predictive value (57.15%)

Article Details

Keywords

Pulmonary embolism, sPESI index, CRP-hs, mortality in 30 days

References

1. Hoang Bui Hai, Do Doan Loi, Nguyen Dat Anh. SO SÁNH MÔ HÌNH PESI KINH ĐIỂN VÀ MÔ HÌNH PESI GIẢN LƯỢC ĐỂ TIÊN LƯỢNG TỬ VONG TRONG THÁNG ĐẦU TIÊN DO TẮC ĐỘNG MẠCH PHỔI CẤP. Tạp chí nghiên cứu y học. 2014;91(5):42-6.
2. Karataş MB, İpek G, Onuk T, Güngör B, Durmuş G, Çanga Y, et al. Assessment of Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Pulmonary Embolism. Acta Cardiol Sin. 2016;32(3):313-20.
3. Ma Y, Mao Y, He X, Sun Y, Huang S, Qiu J. The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism. BMC cardiovascular disorders. 2016;16:123.
4. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clinical immunology. 2005;117(2):104-11.
5. Kilic T, Gunen H, Gulbas G, Hacievliyagil SS, Ozer A. Prognostic role of simplified Pulmonary Embolism Severity Index and the European Society of Cardiology Prognostic Model in short- and long-term risk stratification in pulmonary embolism. Pak J Med Sci. 2014;30(6):1259-64.
6. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Archives of internal medicine. 2010;170(15):1383-9.
7. RIGHINI M, ROY P-M, MEYER G, VERSCHUREN F, AUJESKY D, LE GAL G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. Journal of Thrombosis and Haemostasis. 2011;9(10):2115-7.
8. Abul Y, Karakurt S, Ozben B, Toprak A, Celikel T. C-reactive protein in acute pulmonary embolism. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2011;59(1):8-14.